Susanna Naggie, MD

Publications

Osinusi, A, Chary, A, Winters, MA, Naggie, S, Masur, H, Polis, MA, Kottilil, S, and Holodniy, M. "IL28B polymorphism is not associated with HCV protease diversity in patients co-infected with HIV and HCV treated with pegylated interferon and ribavirin." J Med Virol 84, no. 10 (October 2012): 1522-1527.

PMID
22930497
Full Text

Naggie, S, Osinusi, A, Himmel, T, Lucas, J, Thompson, JW, Dubois, LG, Moseley, MA, Clark, PJ, Kottilil, S, and Patel, K. "Targeted proteomics signature identifies corticosteroid binding globulin peptides as highly predictive of treatment response in IL28B unfavorable genotype patients." October 2012.

Scholars@Duke

Clark, PJ, Santoro, R, Piazzolla, V, Mottola, L, Bacca, D, Dello Iacono, N, Grimaldi, S, Quarta, A, Urban, TJ, Naggie, S, Patel, K, Thompson, AJ, Muir, AJ, and Mangia, A. "Optimizing ribavirin dose is critical for sustained viral response in patients with thalassemia major treated for chronic hepatitis C." October 2012.

Scholars@Duke

Norton, BL, Park, L, McGrath, LJ, Proeschold Bell, RJ, Muir, AJ, and Naggie, S. "Health care utilization in HIV-infected patients: assessing the burden of hepatitis C virus coinfection." AIDS Patient Care STDS 26, no. 9 (September 2012): 541-545.

PMID
22860997
Full Text

Clark, PJ, Thompson, AJ, Zhu, Q, Vock, DM, Zhu, M, Patel, K, Harrison, SA, Naggie, S, Ge, D, Tillmann, HL, Urban, TJ, Shianna, K, Fellay, J, Goodman, Z, Noviello, S, Pedicone, LD, Afdhal, N, Sulkowski, M, Albrecht, JK, Goldstein, DB, McHutchison, JG, and Muir, AJ. "The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection." Dig Dis Sci 57, no. 8 (August 2012): 2213-2221.

PMID
22543885
Full Text

Naggie, S, Osinusi, A, Katsounas, A, Lempicki, R, Herrmann, E, Thompson, AJ, Clark, PJ, Patel, K, Muir, AJ, McHutchison, JG, Schlaak, JF, Trippler, M, Shivakumar, B, Masur, H, Polis, MA, and Kottilil, S. "Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response." Hepatology 56, no. 2 (August 2012): 444-454.

PMID
22331604
Full Text

Osinusi, A, Naggie, S, Poonia, S, Trippler, M, Hu, Z, Funk, E, Schlaak, J, Fishbein, D, Masur, H, Polis, M, and Kottilil, S. "ITPA gene polymorphisms significantly affect hemoglobin decline and treatment outcomes in patients coinfected with HIV and HCV." J Med Virol 84, no. 7 (July 2012): 1106-1114.

PMID
22585729
Full Text

Clark, PJ, Thompson, AJ, Jazwinski, A, Tillmann, HL, Naggie, S, Muir, AJ, and Patel, K. "Association of Serum Adipocytokines With IL28B and SVR in Chronic Hepatitis C." May 2012.

Scholars@Duke

Clark, PJ, Thompson, AJ, Zhu, M, Vock, DM, Zhu, Q, Ge, D, Patel, K, Harrison, SA, Urban, TJ, Naggie, S, Fellay, J, Tillmann, HL, Shianna, K, Noviello, S, Pedicone, LD, Esteban, R, Kwo, P, Sulkowski, MS, Afdhal, N, Albrecht, JK, Goldstein, DB, McHutchison, JG, Muir, AJ, and IDEAL investigators, . "Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response." J Viral Hepat 19, no. 5 (May 2012): 332-340.

PMID
22497812
Full Text

Naggie, S, and Sulkowski, MS. "Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals." Gastroenterology 142, no. 6 (May 2012): 1324-1334.e3. (Review)

PMID
22537439
Full Text

Pages